News & Events
NASHVILLE, Sept. 10, 2019 — PathGroup, one of the largest private providers of pathology, clinical and molecular laboratory services in the United States, announced today that Southeastern Pathology Associates has joined the PathGroup family of pathology practices and laboratories.
Click here to read the press release.
Due to the threat of Hurricane Dorian, PathGroup specimen transportation services for the coastal regions of GA, SC and NC will be impacted.
Click here to learn more.
More than 50 million Americans suffer from allergies every year making allergies the sixth leading cause of chronic illness in the United States. Allergies are a common, yet overlooked, disease and the most common health issue that affects children in the U.S. An estimated 4.2 million children in the U.S. have a food allergy to things like peanuts, eggs, milk, wheat, tree nuts, fish and shellfish.
Click here to learn more.
July 28 is World Hepatitis Day. In 2016, every country in the world signed up to eliminate viral hepatitis by 2030 and World Hepatitis Day is an annual reminder to continue that fight. Viral hepatitis (most notably hepatitis A, B, and C) kills an estimated 1.4 million people every year around the world, but these deaths are preventable with early detection.
In the United States, viral hepatitis affects millions of people, with hepatitis C affecting the largest population – about 40,000 new cases of acute hepatitis C every year. An estimated 2.4 million people in the United States are living with chronic hepatitis C, which occurs if acute hepatitis C infection is left untreated.
PathGroup offers many testing options to help healthcare providers diagnose viral hepatitis in their patients. Visit http://www.pathgroup.com/clinical/testing-menu/ for a full list of testing options.
Effective June 10, 2019, PathGroup has introduced a new automated and semi-quantitative optical measurement system from Roche Diagnostics for the assessment of elevated triglycerides (lipemia), hemoglobin (hemolysis) and bilirubin (icterus) in human serum and plasma specimens. The new procedure will replace the historical subjective visual inspection procedure for marked elevations in these interfering substances. This new procedure will be performed on all plasma and serum specimens with conventional clinical chemistry and immunochemistry tests performed on the Roche analyzers. Please note that serum indices testing is independent from the assessment of unspun or partially spun specimens.
Click here to learn more.
Effective June 24, 2019, PathGroup will begin calculating estimated glomerular filtration rate by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation instead of the previously utilized Modification of Diet in Renal Disease (MDRD) equation. eGFR values are derived from patient specific factors including, serum creatinine, age, gender, and race and are used to assess the kidney’s filtering capacity. While both equations are accurate below 60 mL/min/1/73 m2, the CKD-EPI equation provides a more accurate value above this threshold. This change will allow PathGroup to report numeric eGFR values for results greater than 60 mL/min/1.73 m2.
Click here to learn more.
Reported cases of vector-borne diseases – diseases contracted from mosquito or tick bites – have tripled since the early 2000s.
Depending on the patient’s geographic location or recent travel destinations, they could be at risk of contracting diseases from ticks and mosquitos.
To learn more, click here.
May 25 is World Thyroid Day. Thyroid disorders affect an estimated 20 million people in the United States – that’s more than 12% of the U.S. population. Thyroid disorders like hyperthyroidism, hypothyroidism, Graves disease, and even thyroid cancer are caused by abnormal activity in the thyroid that can be detected using laboratory testing. PathGroup offers tests that assist healthcare providers in diagnosing thyroid disorders in their patients. To learn more about these testing options, visit the online Directory of Services.
On February 10, 2019, PathGroup introduced new automated clinical chemistry instrumentation manufactured by Roche Diagnostics. At that time, our reported reference ranges were based on Roche FDA cleared or approved product labeling and as validated in correlation studies performed at PathGroup.
Click here to read more.
NASHVILLE, May 1, 2019 — PathGroup, one of the largest private providers of pathology, clinical and molecular laboratory services in the United States, today announced that it has acquired Pathologists Bio-Medical Laboratories (PBM), a leading provider of pathology services based in Dallas.
Click here to read the press release.
